Rightmove and Rentokil are 2 FTSE 100 shares in the news. Should I buy?

Two FTSE 100 shares hit the headlines today (11 September) for very different reasons. Our writer ponders whether now could be a buying opportunity.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Rightmove (LSE:RMV) and Rentokil (LSE:RTO) are two FTSE 100 shares that attracted a lot of interest on 11 September. That’s because the former rejected a takeover approach and the latter released a disappointing trading update.

But should I add either of them to my portfolio?

Hot property

On 2 September, Rightmove announced that it had received an unexpected takeover approach from REA Group, an Australian company that operates a number of real estate websites around the world.

In my opinion — although a potential acquisition makes sense from a strategic point of view — they’ve offered too much. If I was a shareholder, I’d be screaming from the rooftops for the directors to agree to the deal. Instead, they’ve rejected the bid.

For the year ending 31 December 2024 (FY24), analysts are expecting basic earnings per share (EPS) of 25.98p. The offer values the company at 698p — implying a forward price-to-earnings ratio of 26.5. To put this in perspective, the Magnificent Seven are currently trading on a multiple of 23.9.

And I think there’s little on the company’s balance sheet to justify this valuation. At 30 June 2024, it had net assets of £66m, giving an eye-watering price-to-book ratio of 80.

But when the takeover approach was rejected, Rightmove’s share price didn’t move. This suggests shareholders are expecting an improved offer to be made by REA (or someone else). Collectively, investors clearly believe the company’s worth at least £5.3bn, its current market cap.

That could be due to the fact that it has an 86% market share of a “selection of the top property portals”.

It should also benefit from the anticipated improvement in the UK property market if (as expected) interest rates continue to be cut.

Also, the government’s emphasis on housebuilding to help boost economic growth should add to the property portal’s bottom line.

But despite these positives, its current valuation looks on the high side to me. I don’t see much further upside, therefore I wouldn’t want to invest.

Bad news

Rentokil’s shares tanked nearly 20% after the pest control and hygiene group issued a profits warning after reporting disappointing sales in North America. The territory accounts for approximately 60% of revenue so any problems in the region are going to have a disproportionate impact.

On the day, the stock hit a 52-week low. It’s not been a good year for the company’s shareholders. Its shares have fallen 34% since September 2023.

But this could be an opportunity to get a quality stock at a knock-down price.

Through a combination of acquisitions and organic growth, Rentokil has seen its revenue increase from £2.7bn in 2019, to £5.4bn in 2023. During this period, its adjusted EPS has risen by an impressive 61%.

But I don’t want to buy, principally because I still think there’s some uncertainty over its business in America. It doesn’t sound as though things have improved. The company said “the trading performance in July and August was lower than anticipated”.

This makes me nervous.

Also, Rentokil’s dividend is on the mean side. It increased its interim payout by an impressive 14.9%, compared to FY23. But even if it did this with its final dividend, it would still only be yielding 2.6%.

This isn’t enough to compensate me for the risk that I’d be taking by investing now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Beard has no position in any of the shares mentioned. The Motley Fool UK has recommended Rightmove Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Wall Street sign in New York City
Investing Articles

Want to profit from the next stock market crash? 2 things to do now!

Our writer is not spending a moment trying to predict the timing of the next stock market crash. Instead, he's…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Is Tesla stock a brilliant bargain lots of people don’t see?

Someone buying Tesla stock last month could already have seen it rise over 50%. What's going on -- and should…

Read more »

A senior woman and young girl help out in the greenhouse at the local farm.
Investing Articles

£10k invested in M&G shares 5 years ago would have generated a second income of…

Harvey Jones says the super-sized 9% yield from M&G shares has delivered a generous second income stream even though the…

Read more »

Close-up of British bank notes
Investing Articles

3 UK shares to consider for a 6.6%+ dividend yield

Christopher Ruane discusses a trio of blue-chip UK shares investors should consider for their commercial prospects and above-average dividend yields.

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Here’s how someone could start investing for the first time with a spare £400

It doesn't have to take huge sums to start investing. Here, Christopher Ruane outlines how someone could start with just…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

I’ve been following Warren Buffett to handle this weird 2025 stock market! Here’s how

Christopher Ruane has been using some Warren Buffett wisdom to help him navigate uncertain stock markets. Here's the approach he's…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

£9,000 in savings? Here’s how that could earn £285 a month in passive income

Fed up of unrealistic passive income ideas? Our writer shows how putting under £10k into dividend shares now could hopefully…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

I asked ChatGPT to suggest 3 UK dividend stocks for further research. Here’s what it said

Can artificial intelligence come close to the real thing in my search for long-term dividend stocks? No, but it's a…

Read more »